Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents

Chemico-Biological Interactions

Volumn 157-158, Issue , 2005, Pages 219-226

  Barak, Dov ^a   Ordentlich, Arie ^a   Kaplan, Dana ^a   Kronman, Chanoch ^a   Velan, Baruch ^a   Shafferman, Avigdor ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Carbamates; Donepezil; Galanthamine; Pyridostigmine; Rivastigmine

Indexed keywords

CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; GLUTAMIC ACID; HISTIDINE; PYRIDOSTIGMINE; RIVASTIGMINE; TACRINE; TRYPTOPHAN; TYROSINE;

ALZHEIMER DISEASE; BINDING SITE; CHEMICAL BOND; CONFERENCE PAPER; COVALENT BOND; GENE MAPPING; MUTAGENESIS; STRUCTURE ANALYSIS; TORPEDO CALIFORNICA;

ACETYLCHOLINESTERASE; ACYLATION; ALZHEIMER DISEASE; ANIONS; BINDING SITES; CATIONS; CHOLINESTERASE INHIBITORS; HUMANS; MUTATION; OXYGEN;

MAMMALIA; TORPEDO CALIFORNICA;

EID: 28744438871     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.10.030     Document Type: Conference Paper

References (21)

1. E. Giacobini E. Giacobini Cholinesterases and Cholinesterase Inhibitors 2000 Martin Dunitz Ltd. London
2. J.L. Sussman, M. Harel, F. Frolow, C. Oefner, A. Goldman, L. Toker, and I. Silman Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein Science 253 1991 872 879
3. G. Kryger, M. Harel, K. Giles, L. Toker, B. Velan, A. Lazar, C. Kronman, D. Barak, N. Ariel, A. Shafferman, I. Silman, and J.L. Sussman Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II Acta Crystallogr. 56 2000 1385 1394
4. A. Shafferman, B. Velan, A. Ordentlich, C. Kronman, H. Grosfeld, M. Leitner, Y. Flashner, S. Cohen, D. Barak, and N. Ariel Substrate inhibition of acetylcholinesterase residues affecting signal transduction from the surface to the catalytic center EMBO J. 11 1992 3561 3568
5. P. Taylor, and Z. Radic The cholinesterases Annu. Rev. Pharmacol. Toxicol. 34 1994 281 320
6. A. Ordentlich, D. Barak, C. Kronman, Y. Flashner, M. Leitner, Y. Segall, N. Ariel, S. Cohen, B. Velan, and A. Shafferman Dissection of the human residues constituting the anionic site, the hydrophobic site, and the acyl pocket J. Biol. Chem. 268 1993 17083 17095
7. D. Barak, C. Kronman, A. Ordentlich, N. Ariel, A. Bromberg, D. Marcus, A. Lazar, B. Velan, and A. Shafferman Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core J. Biol. Chem. 269 1994 6296 6630
8. N. Ariel, A. Ordentlich, D. Barak, T. Bino, B. Velan, and A. Shafferman The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors Biochem. J. 335 1998 95 102
9. D. Kaplan, A. Orentlich, D. Barak, N. Ariel, C. Kronman, B. Velan, and A. Shafferman Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase Biochemistry 41 2002 8245 8252
10. A. Ordentlich, D. Barak, C. Kronman, H.P. Benschop, L.P. De Jong, N. Ariel, R. Barak, Y. Segall, B. Velan, and A. Shafferman Exploring the active center of human acetylcholinesterase with stereoisomers of an organophosphorus inhibitor with two chiral centers Biochemistry 38 1999 3055 3066
11. A. Shafferman, D. Barak, D. Kaplan, A. Ordentlich, C. Kronman, B. Velan, Functional requirements for the optimal catalytic configuration of the AChE active center, this issue.
12. M. Harel, I. Schalk, L. Ehert-Sabatier, F. Bouet, M. Goeldner, C. Hirth, P.H. Axelson, I. Silman, and J.L. Sussman Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase Proc. Natl. Acad. Sci. U.S.A. 90 1993 9031 9035
13. G. Kryger, I. Silman, and J.L. Sussman Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs Structure 7 1999 297 307
14. H.M. Greenblatt, G. Kryger, T. Lewis, I. Silman, and J.L. Sussman Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3A resolution FEBS Lett. 463 1999 321 326
15. P. Bar-On, C.B. Millard, M. Harel, H. Dvir, A. Enz, J.L. Sussman, and I. Silman Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine Biochemistry 41 2002 3555 3564
16. A. Shafferman, C. Kronman, Y. Flashner, M. Leitner, H. Grosfeld, A. Ordentlich, Y. Gozes, S. Cohen, N. Ariel, D. Barak, M. Harel, I. Silman, J.L. Sussman, and B. Velan Mutagenesis of human acetylcholinesterase J. Biol. Chem. 267 1992 17640 17648
17. D. Barak, D. Kaplan, A. Ordentlich, N. Ariel, B. Velan, and A. Shafferman The 'aromatic trapping' of the catalytic histidine is essential for efficient catalysis of acetylcholinesterase Biochemistry 41 2002 8245 8252
18. A. Ordentlich, D. Barak, C. Kronman, N. Ariel, Y. Segall, B. Velan, and A. Shafferman Functional characteristics of the oxyanion hole in human acetylcholinesterase J Biol. Chem. 273 1998 19509 19517
19. M. Harel, D.M. Quinn, H.K. Nair, I. Silman, and J.L. Sussman The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic powerand substrate specificity of acetylcholinesterase J. Am. Chem. Soc. 118 1996 2340 2346
20. D. Kaplan, D. Barak, A. Ordentlich, C. Kronman, B. Velan, and A. Shafferman Is aromaticity essential for trapping the catalytic His447 in human acetylcholinesterase Biochemistry 43 2004 3129 3136
21. C. Bartolucci, E. Perola, L. Cellai, M. Brufani, and D. Lamba "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase Biochemistry 38 1999 5714 5719